Method for in-vitro stabilization of heavy metals

Abstract

This invention provides a method for reducing the level of 1.0 Normal HCL soluble heavy metals within the human stomach acid environment by oral ingestion of stabilizing agents such that the heavy metal solubility is reduced and subsequent heavy metal transfer to the blood stream is reduced to acceptable levels or eliminated.

1 . A method of reducing the solubility of heavy metal within the human stomach, comprising oral ingestion of at least one stabilizing agent in an amount effective in reducing the solubility of heavy metal to desired levels. 
   
   
       2 . The method of  claim 1 , wherein the stabilizing agent is selected from the group consisting of phosphates, phosphoric acid, technical grade phosphoric acid, wet process produced amber or green phosphoric acid, potassium chloride, sodium chloride, calcium chloride, iron powder, ferric sulfate, ferrous sulfate, ferric chloride, hexametaphosphate, polyphosphate, calcium orthophosphate, superphosphates, triple superphosphates, phosphate rock, bone phosphate, fishbone phosphates, tetrapotassium polyphosphate, monocalcium phosphate, monoammonia phosphate, diammonium phosphate, dicalcium phosphate, tricalcium phosphate, trisodium phosphate, salts of phosphoric acid, and combinations thereof.